INTU
51
2
TGT
25
-24
PBI
60
-5
BBY
40
3
EIX
77
2
LB
34
8
VTR
49
-3
HAS
30
2
ICE
59
-3
AFL
46
-3
MTB
63
-2
F
43
-8
DAL
80
-4
XEL
67
2
MRO
55
3
MRK
22
3
CSX
51
-2
AVGO
20
-5
ED
48
3
PRU
57
-3
INTU
51
2
TGT
25
-24
PBI
60
-5
BBY
40
3
EIX
77
2
LB
34
8
VTR
49
-3
HAS
30
2
ICE
59
-3
AFL
46
-3
MTB
63
-2
F
43
-8
DAL
80
-4
XEL
67
2
MRO
55
3
MRK
22
3
CSX
51
-2
AVGO
20
-5
ED
48
3
PRU
57
-3
Financhill
Back

Protalix BioTherapeutics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80

PLX
Protalix BioTherapeutics

Last Price:
1.65
Seasonality Move:
78.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Protalix BioTherapeutics Price Quote

$1.65
-0.04 (-2.37%)
(Updated: November 21, 2024 at 3:00 PM ET)

Protalix BioTherapeutics Key Stats

Buy
80
Protalix BioTherapeutics (PLX) is a Buy
Day range:
$1.61 - $1.74
52-week range:
$0.82 - $1.90
Dividend yield:
0%
P/E ratio:
18.44
P/S ratio:
2.85
P/B ratio:
3.77%
Volume:
817.1K
Avg. volume:
345.1K
1-year change:
21.58%
Market cap:
$122.2M
Revenue:
$65.5M
EPS:
$-0.16

How Much Does Protalix BioTherapeutics Make?

Is Protalix BioTherapeutics Growing As A Company?

Protalix BioTherapeutics Stock Price Performance

What Is Protalix BioTherapeutics 52-Week High & Low?

Protalix BioTherapeutics Price To Free Cash Flow

Is It Risky To Buy Protalix BioTherapeutics?

Is Protalix BioTherapeutics Cash Flow Positive?

  • What Is PLX Cash Flow From Operations?
    Cash flow from operations (TTM) is $8.3M
  • What Is Protalix BioTherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$20.4M
  • What Is Protalix BioTherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $19.2M

Protalix BioTherapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    PLX return on invested capital is -19.69%
  • What Is Protalix BioTherapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -11.58%
  • What Is PLX Return On Equity?
    ROE is a measure of profitability and is -29.54%

Protalix BioTherapeutics Earnings Date & Stock Price

Protalix BioTherapeutics Competitors

Protalix BioTherapeutics Dividend Yield

Protalix BioTherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 73.6% 9.72%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 14.00
Upside from Last Price: 728.4%

Major Shareholders

  • How many PLX shares are owned by institutional investors?
    6.6M PLX shares are owned by institutional investors
  • How many PLX shares are owned by insiders?
    4.7M PLX shares are owned by insiders